When it comes to research regarding cancer and its therapies, there are individuals who must be given credit due to their impacts in finding solutions to this menace. Mikhail Blagosklonny is one of such names; he is a professor of Oncology at the Rosewell Park Cancer Institute in Buffalo, New York. Mikhail has conducted numerous research projects in cancer and its therapy. He is popular in his advocacy on the use of Rapamycin, a cancer drug whose role is to lengthen the lifespan of the cancer patient. His contribution in this particular field of research is extensive and unparalleled.The work of Mikhail Blagosklonny is driven by his passion to ensure that individuals across the globe can access the best treatment possible irrespective of their financial muscles. Medical research is his area of focus and narrowed specifically on the study of aging as well as cancer. He is specifically interested in finding out the connection between age and cancer. Blagosklonny is interested in understanding why cancer is common in patients above a certain age. He continues to advance research that has and will continue to be of great value in the oncology field.
Mikhail Blagosklonny continues to be a very influential individual. Apart from being a valuable researcher, he is a professor with expertise in his field of specialization. He continues to be a source of inspiration to not only his students but also his peers who want to expand their careers. Mikhail’s interesting topic of cancer, as well as aging, has attracted great attention from experts in the medical field. He has a goal of not only developing a treatment for cancer but also treating the disease effectively and affordably, not the expensive treatment that is there today. Mikhail Blagosklonny seeks to find ways in which the cancerous cells in the body can be eliminated without having adverse effects on the normal cells. Cells are crucial in the recovery of the body and mind of a patient after months or years of treatment. He has made critical progress in this field, and his findings will inspire other researchers across the globe to pick up from where he will leave his research. He believes that effective treatment of cancer in the future will not only be achievable for the rich peoples; it would be a cost-effective treatment for everybody.
Rapamycin is a drug that Mikhail Blagosklonny continues to promote in the treatment of cancer as well as prolonging the lifespan of a human being. Increasing the longevity of human beings is his current research area. He has carried out tests on mice and has proved that employment of Rapamycin on aging mice has enhanced the immunity of these animals on diseases such as tuberculosis. Moreover, tests on human beings have also proven immunological innovation among the elderly when injected with the dose of Rapamycin before being immunized against influenza. Mikhail Blagosklonny continues to provide hope to the long search for effective cancer treatment. His efforts have continued to give people hope against the menace of cancer.